The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 91, Issue 3, 1986, Pages 344-349

  Ferguson, M K ^a   Little, A G ^a   Golomb, H M ^a   Hoffman, P C ^b   DeMeester, T R ^b   Beveridge, R ^b   Skinner, D B ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PROCARBAZINE;

ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; MAJOR CLINICAL STUDY; MEDIAN SURVIVAL TIME; PRIORITY JOURNAL; RADIOTHERAPY; RESPIRATORY SYSTEM; SURVIVAL; THERAPY; THORAX SURGERY;

EID: 0022633001     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5223(19)36049-0     Document Type: Article

References (14)

1. Newman SB DeMeester TR Golomb HM Hoffman PC Little AG Raghavan V Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma J T horac C ardiovasc S urg 86 1983 180 185
2. Martini N Flehinger BJ Nagasaki F Hart B Prognostic significance of Nl disease in carcinoma of the lung J T horac C ardiovasc S urg 86 1983 646 653
3. American Joint Committee for Cancer Staging and End-Results Reporting. Manual for Staging of Lung Cancer 1979 Whiting Press Chicago
4. Lee E Desu M A computer program for comapring k samples with right-censored data Comput Programs Biomed 2 1972 315 321
5. Kaplan EL Meier P Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
6. Kirsh MM Rotman H Argenta L Bove E Cimmino V Tashian J Ferguson P Sloan H Carcinoma of the lung. Results of treatment over ten years Ann Thorac Surg 21 1976 371 377
7. Vincent RG Takita H Lane WW Gutierrez AC Pickren JW Surgical therapy of lung cancer J T horac C ardiovasc S urg 71 1976 581 591
8. Mountain CF Assessment of the role of surgery for control of lung cancer Ann Thorac Surg 24 1977 365 373
9. Matthews MJ Kanhouwa S Pickren J Robinette D Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer Cancer Chemother Rep 4 1973 63 67
10. Green N Kurohara SS George FW Crews QE Jr Postresection irradiation for primary lung cancer Radiology 116 1975 405 407
11. Cooper JD Pearson FG Todd TRJ Patterson GA Ginsberg RJ Basiuk J Blair V Cass W Radiotherapy alone for patients with operable carcinoma of the lung Chest 87 1985 289 292
12. Bitran JD Golomb HM DeMeester TR Desser RK Hoffman P Cohen L Green M Sovik C Combined modality therapy for Stage III non–small cell bronchogenic carcinoma (NSBC) Proc Am Soc Clin Oncol 21 1980 446
13. Bitran JD Desser RK DeMeester TR Shapiro CM Billings A Rubenstein L Evans R Colman M Rao Y Griem M Golomb HM Combined modality therapy for Stage III MO non-oat cell bronchogenic carcinoma Cancer Treat Rep 62 1978 327 332
14. Shields TW Yee J Conn JH Robinette CD Relationship of cell type and lymph node metastasis to survival after resection of bronchial carcinoma Ann Thorac Surg 20 1975 501 510